This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
Hospices coast-to-coast have undergone leadership transitions, including changes in legal executives and a slew of newly appointed CEOs, among other roles in the industry. Texas-based New Day provides homehealth, hospice, palliative and personal care services across 31 locations in Illinois, Kansas, Missouri and in its home state.
s (Nasdaq: AMED) hospice segment has seen headwinds impact admissions growth as the company awaits its pending acquisition by the UnitedHealth Group (NYSE: UNH) subsidiary Optum. The company’s hospice segment revenue reached $207.9 Gross margin for the hospice segment fell slightly to 42.9% Amedisys Inc.’s year-over-year.
Texas-based New Day Healthcare LLC has announced its acquisition of Good Samaritan Society’s hospice operations in its home state. The transaction includes Good Samaritans hospice assets in El Paso, Texas, expanding New Days existing presence in that market. Hospice utilization rates hovered at 49.1% Scott Herman.
The hospice industry is undergoing a transformative period of rising demand and regulatory changes. This is according to Scott Levy, chief government affairs officer at National Alliance for Care at Home (the Alliance). working hand-in-glove on policy issues with colleagues across the homehealth and hospice industries.
Staff development, technology adoption and steady organic growth are top priorities for Family Hospice CEO Charles Hall as he takes the helm at that organization. Family Hospice was founded by Jack Draughon and Mark Kempsey three years ago. My father had been in hospice. Army officer.
Congressional legislators are casting doubts on regulatory oversight of Medicare Advantage plans over concerns about spending, claims denials, and end-of-life care. Department of Health & Human Services Office of the Inspector General (OIG), the Medicare Payment Advisory Commission (MedPAC), and the Government Accountability Office.
Scott Herman, CEO of New Day Healthcare, told Hospice News in an email. Having expanded PCS services in Houston allows us to engage a full home care continuum, furthering our longitudinal care strategy. Similar to national demographic trends, a growing aging population is driving demand for hospice in Texas. Census Bureau.
The Ohio-based health system Adena Health has unveiled a hospice and homehealth joint venture with Alternate Solutions Health Network (ASHN). The JV, branded as Adena HomeHealth and Hospice, will launch next month, providing care to seriously and terminally ill patients in south central and southern Ohio.
Though many expect a hospice M&A rebound in 2024, the scales are tipping in favor of homehealth companies among buyers. After 2023’s slump, PE firms have been sitting on more than $800 million in dry powder, according to data shared with Hospice News by The Braff Group. But additional data point to a resurgence.
A new hospice nursing recruitment effort has launched in the New England region after being stalled by the pandemic. The recruitment initiative is the fruit of a collaboration between Visiting Nurse and Hospice for Vermont and New Hampshire (VNH) and the Home Care, Hospice & Palliative Care Alliance of New Hampshire (the Alliance).
NASDAQ: PNTG) has acquired Guardian Hospice and Guardian Hospice of Oklahoma for an undisclosed amount. Guardian Hospice of Oklahoma received Medicare certification in 2015 and has since grown its presence in the state and across Texas. Centers for Medicare & Medicaid Services (CMS). The Pennant Group Inc.
Cameron Muir has been named as the new CMO of the National Partnership for Healthcare and Hospice Innovation (NPHI). His new title signals the organization’s strategic plans to reshape hospice care delivery through patient-centered, innovative approaches, according to NPHI CEO Tom Koutsoumpas.
Today’s health care environment is flooded with data, but hospice leaders should include three types of indicators in mind as they assess their performance. Numbers like costs-per-day, payer-specific margins, and measures of community support can paint a picture of an organization’s position, executives told Hospice News.
Some hospice owners have been selling their businesses soon after securing a license. The practice appears to stem from a rash of newly licensed hospices that have emerged in California, Nevada, Texas and Arizona. Some of these providers have secured licenses, as well as Medicare certification and, sometimes, accreditation.
Hospices seeking to gauge the potential impact of new regulatory actions in the space can look to their counterparts in the homehealth field. We then started seeing the greater degree of impact,” Dombi told Hospice News. CMS is no doubt hoping for similar results for the MedicareHospice Benefit.
Todays hospice landscape is reaching a pivotal point of evolutionary growth that has come with increased oversight as regulators seek to curb fraudulent activity in the space, according to Bill Dombi, senior counsel for the law firm Arnall Golden Gregory (AGG). What are the leading legal concerns facing hospice providers right now?
Hospice transactions are facing a new world of challenges during a time when M&A activity is projected to ramp up after recent lulls. More founders who began their organizations when the MedicareHospice Benefit was established in the 1980s are reaching retirement. Who’s going to receive the proceeds?
The National Association for Home Care & Hospice (NAHC) and the National Hospice and Palliative Care Organization (NHPCO) are moving forward on the integration of their combined new organization. Announced in June at the Hospice News Elevate conference in Washington D.C. Earl Blumenauer (D-Oregon).
This year has brought both tumultuous challenges and evolving opportunities for hospices that will steer hospice leadership during 2024. Hospice News spoke with a group of industry leaders about the most impactful forces that will shape the space in the coming year. CEOs and other hospice executives also noted emerging themes.
Regulators have been keeping an increasingly close watch on hospice providers, and this may intensify in 2023. Moving into next year, hospices have a spectrum of crucial issues on their plates. Hospice will have a lot going on in the regulatory space next year. What do hospices need to be focused on and ready for?
Hospices considering a sale should not underestimate their value proposition by limiting their focus on revenues and margins. With hospice M&A staying hot, a host of operational and financial pressures — coupled with record-high valuations in the space — has driven a range of providers to consider selling.
While hospice and homehealth M&A continue to burgeon, non-medical home care is starting to slip out from under their shadows. Deal volume for non-medical home care companies outstripped that for hospice or homehealth during the first half of the year. Hospice market to stay mighty.
New rules for changes in hospice ownership are likely to slow down or kill some mergers and acquisitions, according to Ari Markenson, partner at the law firm Venable LLP. Another recently proposed rule would require anyone who holds 5% ownership or more in a hospice must submit to a criminal background check, including fingerprints.
Addus HomeCare Corporation’s (NASDAQ: ADUS) is shifting its M&A strategy away from hospice deals to focus on its homehealth and personal care businesses. Texas-based Addus provides personal, homehealth and hospice care across 207 locations in 22 states, reaching roughly 46,500 patients annually.
s (NYSE: EHAB) M&A journey has narrowed towards hospice, diverting less in homehealth’s direction. Reimbursement uncertainties, shrinking pools of available assets, and rising valuations in the homehealth space are forces steering the company’s sights towards hospice, according to Enhabit executives.
The future of telehealth in hospice care delivery is among the questions swirling around the expiration of the COVID-19 public health emergency (PHE) on May 11. Though initially the telehealth waivers weren’t intended to be permanent, they will likely have long-term impacts in hospice.
Hospice acquisition volumes and price tags have hit record highs for several years running. While a sizzling hospice market saw a cooled start this year, merger and acquisition activity is still outpacing other health care sectors. How has the hospice market been shaping up this year compared to others?
Though hospice deal volume dipped in 2022 compared to previous years, five particular transactions could paint a larger picture of where investors see value in the space. These interesting, unusual or groundbreaking deals could signal what’s to come in 2023 and help shape the hospice market’s long-term future. This was Humana Inc.’s
While homehealth operators brace for the impact of the meager 2023 reimbursement rates, hospices likewise must prepare for a ripple effect. Centers for Medicare & Medicaid Services (CMS) recently established a 0.7% base rate payment increase for homehealth care in 2023.
Enhabit HomeHealth & Hospice (NYSE: EHAB) is running against the wind right out of the gates due to labor and capacity constraints — but remains poised for hospice acquisitions as the rest of this year unfolds. Enhabit currently operates 99 hospice locations and 252 homehealth locations across 34 states.
This article is based on a Hospice News discussion with Maria Warren, Vice President of Clinical Consulting at Netsmart that took place at the Hospice News Elevate Conference in Chicago. Hospice News: I am here with Maria Warren and we’re going to talk a little bit about technology and value-based care. Are you not?
Disruption in homehealth reimbursement has an influence on the hospice mergers and acquisitions market, particularly among the rising number of companies offering both services. So many industry consolidators paused all but the most strategic deals and pivoted to hospice. “. A few factors come into play here.
Primarily, Medicare reimburses for palliative care through fee-for-service payment programs that cover physician and licensed independent practitioner services. Already, a growing range of health care providers are investing in those services, including hospices, homehealth agencies, health systems, primary care and other providers.
The pendulum of investor interest has swung hard into the hospice market in recent years, but shifts in reimbursement could steer buyers towards homehealth. Uncertainty earlier this year around Medicare’s proposed 2023 homehealth payment rates led some stakeholders to expect a swerve towards hospice.
When the Atlanta-based provider filed to go public in April 2021, however, it revealed ambitious plans to expand into the arenas of Medicare-certified homehealth and hospice care. “We Hospice, in particular, will be buoyed by a rate increase hitting Oct. As a reminder, we do not have a demand problem.”
The consideration marks another move among large homehealth and hospice providers in the industry. The company is getting ready to explore various transaction options in order to satisfy the terms of its Tax Matters Agreement with Encompass Health Corp. Its hospice segment brought in $48.5 year-over-year decline.
About 40% of 330 hospice professionals who responded to the 2023 Hospice News Outlook Survey and Report said that staff satisfaction and engagement would be the biggest driver of their technology investments this year. Centers for Medicare & Medicaid Services (CMS) increased homehealth base rate payments by only 0.7%
The state is one of three in which Addus offers its trifecta of business lines — personal care, homehealth and hospice. Apple offers homehealth, skilled nursing and rehabilitative therapy services to 450 patients daily across 11 counties in and around the Chicago area. for $85 million earlier this year.
As Addus HomeCare Corporation (NASDAQ: ADUS) sinks teeth into acquisitions, the company will be taking smaller bites when it comes to hospice deals. Addus has indicated for roughly the last year that it will orient its M&A strategy towards its homehealth and personal care services, with hospice becoming less of a priority.
Home-based care provider AccentCare has been busy since its merger with Seasons Hospice & Palliative Care, exploring new technologies and care delivery strategies, as well as expanding business lines. More recently, we’ve started using Muse to really help us to understand patient acuity within hospice.
Homehealth and hospice provider Amedisys acquired the company last June for a price tag of $250 million. Sinai partnership marks Contessa’s first risk-based palliative care contract, which is reimbursed through Medicare Advantage. With this in place, the company now offers a full continuum of home-based care. “We
Hospices considering a sale should not underestimate their value proposition by limiting their focus on revenues and margins. With hospice M&A staying hot, a host of operational and financial pressures — coupled with record-high valuations in the space — has driven a range of providers to consider selling.
The program is designed to recognize up-and-coming industry members who are shaping the next decade of homehealth, hospice care, senior housing, skilled nursing, and behavioral health. Tej Dhillon, founder and CEO of Seva Hospice, has been named a 2024 Future Leader by Hospice News. I knew of the benefit.
The program is designed to recognize up-and-coming industry members who are shaping the next decade of homehealth, hospice care, senior housing, skilled nursing, and behavioral health. Drake Jarman, senior vice president of growth of hospice at Amedisys Inc. Advocating for a comprehensive approach to hospice care.
We organize all of the trending information in your field so you don't have to. Join 5,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content